Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Audited ....
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biofil Chemicals & Pharmaceuticals Ltd has informed exchanges that a Board meeting is scheduled for 30th May 2026 to consider and approve the Audited Financial Results for Q4 as well as the Financial Year ended 31st March 2026. The meeting will also consider the Auditors Report, Statement of Assets and Liabilities, and Cash Flow Statement. The company has confirmed compliance with Regulation 29 of SEBI (LODR) Regulations, 2015. Trading window for insiders will open 48 hours after the declaration of results. This is a routine board meeting intimation and does not contain actual financial results.
This is a procedural disclosure and does not contain financial results. Actual impact on stock price will be determined when the audited financial results are declared on 30th May 2026.